|
[1]MANN JP,TANG GY,NOBILI V,et al.Evaluations of lifestyle,dietary,and pharmacologic treatments for pediatric nonalcoholic fatty liver disease:A systematic review[J].Clin Gastroenterol Hepatol,2019,17(8):1457-1476.e7．
|
|
[2]DOYCHEVA I,ISSA D,WATT KD,et al.Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in young adults in the United States[J].J Clin Gastroenterol,2018,52(4):339-346．
|
|
[3]CRESPO M,LAPPE S,FELDSTEIN AE,et al.Similarities and differences between pediatric and adult nonalcoholic fatty liver disease[J].Metabolism,2016,65(8):1161-1171．
|
|
[4]GOYAL NP,SCHWIMMER JB.The genetics of pediatric nonalcoholic fatty liver disease[J].Clin Liver Dis,2018,22(1):59-71．
|
|
[5]STENDER S,KOZLITINA J,NORDESTGAARD BG,et al.Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci[J].Nat Genet,2017,49(6):842-847．
|
|
[6]BRAUN HA,FAASSE SA,VOS MB.Advances in pediatric fatty liver disease:Pathogenesis,diagnosis,and treatment[J].Gastroenterol Clin North Am,2018,47(4):949-968．
|
|
[7]KO JS.New perspectives in pediatric nonalcoholic fatty liver disease:Epidemiology,genetics,diagnosis,and natural history[J].Pediatr Gastroenterol Hepatol Nutr,2019,22(6):501-510．
|
|
[8]SANTORO N,ZHANG CK,ZHAO H,et al.Variant in the glucokinase regulatory protein(GCKR)gene is associated with fatty liver in obese children and adolescents[J].Hepatology,2012,55(3):781-789．
|
|
[9]FANG YL,CHEN H,WANG CL,et al.Pathogenesis of non-alcoholic fatty liver disease in children and adolescence:From“two hit theory”to“multiple hit model”[J].World J Gastroenterol,2018,24(27):2974-2983．
|
|
[10]DAI D,WEN F,ZHOU S,et al.Association of MTTP gene variants with pediatric NAFLD:A candidate-gene-based analysis of single nucleotide variations in obese children[J].PLo S One,2017,12(9):e0185396．
|
|
[11]CHENG X,YAMAUCHI J,LEE S,et al.APOC3 protein is not a predisposing factor for fat-induced nonalcoholic fatty liver disease in mice[J].J Biol Chem,2017,292(9):3692-3705．
|
|
[12]ISLAM S,WON J,KHAN M,et al.Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitis[J].Ann Hepatol,2019.[Online ahead of print]
|
|
[13]LIN YC,CHANG PF,CHANG MH,et al.A common variant in the peroxisome proliferator-activated receptor-γcoactivator-1αgene is associated with nonalcoholic fatty liver disease in obese children[J].Am J Clin Nutr,2013,97(2):326-331．
|
|
[14]KAWAGUCHI T,SHIMA T,MIZUNO M,et al.Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers[J].PLo S One,2018,13(1):e0185490．
|
|
[15]NOBILI V,ALISI A,VALENTI L,et al.NAFLD in children:New genes,new diagnostic modalities and new drugs[J].Nat Rev Gastroenterol Hepatol,2019,16(9):517-530．
|
|
[16]RINELLA ME.Nonalcoholic fatty liver disease:A systematic review[J].JAMA,2015,313(22):2263-2273．
|
|
[17]MENG L,LUO N,MI J.Impacts of types and degree of obesity on non-alcoholic fatty liver disease and related dyslipidemia in Chinese school-age children?[J].Biomed Environ Sci,2011,24(1):22-30．
|
|
[18]ASSUNCAO S,SORTE N,ALVES CD,et al.Nonalcoholic fatty liver disease(NAFLD)pathophysiology in obese children and adolescents:Update[J].Nutr Hosp,2017,34(3):727-730．
|
|
[19]MCGEOCH LJ,PATEL PR,MANN JP.PNPLA3:A determinant of response to low-fructose diet in nonalcoholic fatty liver disease[J].Gastroenterology,2018,154(4):1207-1208．
|
|
[20]JENSEN T,ABDELMALEK MF,SULLIVAN S,et al.Fructose and sugar:A major mediator of non-alcoholic fatty liver disease[J].JHepatol,2018,68(5):1063-1075．
|
|
[21]O'SULLIVAN TA,ODDY WH,BREMNER AP,et al.Lower fructose intake may help protect against development of nonalcoholic fatty liver in adolescents with obesity[J].J Pediatr Gastroenterol Nutr,2014,58(5):624-631．
|
|
[22]LEGRY V,FRANCQUE S,HAAS JT,et al.Bile acid alterations are associated with insulin resistance,but not with NASH,in obese subjects[J].J Clin Endocrinol Metab,2017,102(10):3783-3794．
|
|
[23]HUSSAIN T,MARGOOB MA,SHOIB S,et al.Prevalence of metabolic syndrome among psychiatric inpatients:A hospital based study from kashmir[J].J Clin Diagn Res,2017,11(6):VC05-VC08．
|
|
[24]HEGARTY R,DEHERAGODA M,FITZPATRICK E,et al.Paediatric fatty liver disease(Pe FLD):All is not NAFLD-Pathophysiological insights and approach to management[J].J Hepatol,2018,68(6):1286-1299．
|
|
[25]VALENTINI D,ALISI A,DI CAMILLO C,et al.Nonalcoholic fatty liver disease in italian children with down syndrome:Prevalence and correlation with obesity-related features[J].J Pediatr,2017,189:92-97.e1．
|
|
[26]GATHERCOLE LL,HAZLEHURST JM,ARMSTRONG MJ,et al.Advanced non-alcoholic fatty liver disease and adipose tissue fibrosis in patients with alstr9m syndrome[J].Liver Int,2016,36(11):1704-1712．
|
|
[27]SHEDLOCK K,SUSI A,GORMAN GH,et al.Autism spectrum disorders and metabolic complications of obesity[J].J Pediatr,2016,178:183-187.e1．
|
|
[28]PATEL KR,WHITE FV,DEUTSCH GH.Hepatic steatosis is prevalent in stillborns delivered to women with diabetes mellitus[J].J Pediatr Gastroenterol Nutr,2015,60(2):152-158．
|
|
[29]BELLATORRE A,SCHERZINGER A,STAMM E,et al.Fetal overnutrition and adolescent hepatic fat fraction:The exploring perinatal outcomes in children study[J].J Pediatr,2018,192:165-170.e1．
|
|
[30]VOS MB,ABRAMS SH,BARLOW SE,et al.NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children:Recommendations from the Expert Committee on NAFLD(ECON)and the North American Society of Pediatric Gastroenterology,Hepatology and Nutrition(NASPGHAN)[J].J Pediatr Gastroenterol Nutr,2017,64(2):319-334．
|
|
[31]DI SESSA A,CIRILLO G,GUARINO S,et al.Pediatric non-alcoholic fatty liver disease:Current perspectives on diagnosis and management[J].Pediatric Health Med Ther,2019,10:89-97．
|
|
[32]ZHOU XL,FU JF.Expert consensus on diagnosis and treatment of nonalcoholic fatty liver disease in children[J].Chin J Pract Pediatr,2018,33(7):487-492.(in Chinese)周雪莲，傅君芬．儿童非酒精性脂肪肝病诊断与治疗专家共识[J]．中国实用儿科杂志，2018,33(7):487-492．
|
|
[33]DI MARTINO M,KORYUKOVA K,BEZZI M,et al.Imaging features of non-alcoholic fatty liver disease in children and adolescents[J].Children(Basel),2017,4(8):73．
|
|
[34]DE LADINGHEN V,WONG GL,VERGNIOL J,et al.Controlled attenuation parameter(CAP)for the diagnosis of steatosis in nonalcoholic fatty liver disease[J].Gastroenterol Hepatol,2016,31(4):848-855．
|
|
[35]CHALASANI N,YOUNOSSI Z,LAVINE JE,et al.The diagnosis and management of non-alcoholic fatty liver disease:Practice guideline by the American Gastroenterological Association,American Association for the Study of Liver Diseases,and American College of Gastroenterology[J].Gastroenterology,2012,142(7):1592-1609．
|
|
[36]WU H,WU YH,TU ZT.Clinical guidelines for general practice[M].Beijing:China Medical Science Press,2018:1.(in Chinese)吴浩，吴永浩，屠志涛．全科临床诊疗常规[M]．北京:中国医药科技出版社，2018:1．
|
|
[37] ZHONG LF.Hygiene[M].Beijing:People's Medical Publishing House,2002:234.(in Chinese)仲来福．卫生学[M]．北京:人民卫生出版社，2002:234．
|
|
[38]SHAKIR AK,SUNEJA U,SHORT KR,et al.Overview of pediatric nonalcoholic fatty liver disease:A guide for general practitioners[J].J Okla State Med Assoc,2018,111(8):806-811．
|
|
[39]National Workshop on Fatty Liver and Alcoholic Liver Disease,Chinese Society of Hepatology,Chinese Medical Association;Fatty Liver Expert Committee,Chinese Medical Doctor Association.Guidelines of prevention and treatment for nonalcoholic fatty liver disease:A 2018update[J].J Clin Hepatol,2018,34(5):947-957.(in Chinese)中华医学会肝病学分会脂肪肝和酒精性肝病学组，中国医师协会脂肪性肝病专家委员会．非酒精性脂肪性肝病防治指南(2018年更新版)[J]．临床肝胆病杂志，2018,34(5):947-957.
|
DownLoad: